Apheresis for chimeric antigen receptor T‐cell production in adult lymphoma patients-Reference-Cited by-同舟云学术

Apheresis for chimeric antigen receptor T‐cell production in adult lymphoma patients

Published:2022-07-19 Issue:8 Volume:62 Page:1602-1611
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Harrer Dennis Christoph¹^ORCID,Heidenreich Martin¹,Fante Matthias Alexander¹,Müller Viktoria²,Haehnel Viola²^ORCID,Offner Robert²,Burkhardt Ralph²,Herr Wolfgang¹,Edinger Matthias¹,Wolff Daniel¹,Thomas Simone¹³,Brosig Andreas²

Affiliation:

1. Department of Internal Medicine III, Hematology and Oncology University Hospital Regensburg Regensburg Germany

2. Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine University Hospital Regensburg Regensburg Germany

3. Leibniz Institute for Immunotherapy Division of Genetic‐Immunotherapy Regensburg Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.17030

Reference20 articles.

1. Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen Receptors

2. Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology

3. Driving cars to the clinic for solid tumors

4. Chimeric Antigen Receptor Therapy

5. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Empfehlung für Leukozytapheresen zur CAR-T-Zell-Herstellung;Transfusionsmedizin;2024-08

3. Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy;BLOOD TRANSFUS-ITALY;2024

4. Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel;Transfusion;2024-02-28

5. Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies;Transplantation and Cellular Therapy;2024-02